| Literature DB >> 30610881 |
Richard Severin1, Ahmad Sabbahi2, Abeer M Mahmoud3, Ross Arena3, Shane A Phillips4.
Abstract
Obesity affects 600 million people globally and over one third of the American population. Along with associated comorbidities, including cardiovascular disease, stroke, diabetes, and cancer; the direct and indirect costs of managing obesity are 21% of the total medical costs. These factors shed light on why developing effective and pragmatic strategies to reduce body weight in obese individuals is a major public health concern. An estimated 60-70% of obese Americans attempt to lose weight each year, with only a small minority able to achieve and maintain long term weight loss. To address this issue a precision medicine approach for weight loss has been considered, which places an emphasis on sustainability and real-world application to individualized therapy. In this article we review weight loss interventions in the context of precision medicine and discuss the role of genetic and epigenetic factors, pharmacological interventions, lifestyle interventions, and bariatric surgery on weight loss.Entities:
Keywords: Cardiovascular disease; Genetics; Healthy living intervention; Precision medicine; Risk; Weight loss
Mesh:
Substances:
Year: 2019 PMID: 30610881 PMCID: PMC6546173 DOI: 10.1016/j.pcad.2018.12.012
Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN: 0033-0620 Impact factor: 8.194